DECIBEL THERAPEUTICS INC (DBTX) Stock News
NASDAQ:DBTX - Nasdaq - US24343R1068 - Common Stock - Currency: USD
DBTX Latest News, Press Relases and Analysis
Health Care Company Regeneron Pharmaceuticals Announces Acquisition of Decibel Therapeutics
Mentions: REGN
Benzinga's 'Stock Whisper' Index: 5 Stocks Investors Are Secretly Monitoring But Not Talking About Yet
Investors are on the hunt for undervalued, underfollowed and emerging stocks, and retail traders have countless methods at their disposal to uncover new information. For some, this may be overwhelming.
Decibel Therapeutics Reports Second Quarter 2023 Financial Results and Corporate Update
- Activated CHORDTM clinical trial sites in U.S., U.K. and Spain and commenced patient screening activities; anticipate dosing first patient in the Phase...
Decibel Therapeutics Reports Second Quarter 2023 Financial Results and Corporate Update
Baird downgrades Decibel to neutral to reflect Regeneron takeover (NASDAQ:DBTX)
Baird has lowered its rating on Decibel Therapeutics (DBTX) to neutral following news that Regeneron (REGN) plans to buy the biotech for up to $213M in cash, including CVRs.
Mentions: REGN
Shareholder Alert: Ademi LLP investigates whether Decibel Therapeutics, Inc. has obtained a Fair Price in its transaction with Regeneron
/PRNewswire/ -- Ademi LLP is investigating Decibel (NASDAQ: DBTX) for possible breaches of fiduciary duty and other violations of law in its transaction with...
Why Is Tango Therapeutics (TNGX) Stock Up 117% Today?
Tango Therapeutics (TNGX) stock is soaring higher on Wednesday after getting a couple of updates from analysts covering the shares.
YELL Stock Alert: Yellow Receives Nasdaq Delisting Notice
Yellow (YELL) stock is falling on Wednesday after the struggling U.S. trucking company received a Nasdaq delisting notice!
Decibel Therapeutics (DBTX) Stock Skyrockets 71% on Regeneron Deal
Decibel Therapeutics (DBTX) stock is soaring higher on Wednesday after signing a deal with Regeneron Pharmaceuticals (REGN).
Decibel stock rises as Regeneron inks buyout deal
Regeneron (REGN) on Wednesday agreed to acquire Decibel Therapeutics (DBTX), a micro-cap biotech focused on gene therapies for $4.00 per share cash. Read more here.
Mentions: REGN
Regeneron to Acquire Decibel Therapeutics, Strengthening Gene Therapy and Hearing Loss Programs
Mentions: REGN
Decibel Therapeutics to Participate in the Upcoming Jefferies Healthcare Conference
BOSTON, June 02, 2023 (GLOBE NEWSWIRE) -- Decibel Therapeutics (Nasdaq: DBTX), a clinical-stage biotechnology company dedicated to discovering and...
Decibel Therapeutics to Participate in the Upcoming Jefferies Healthcare Conference
Decibel Therapeutics to Present DB-020 Phase 1b Clinical Trial Data at the American Society of Clinical Oncology (ASCO) 2023 Annual Meeting
Data from interim analysis support DB-020 as a potential therapy to protect patients against irreversible hearing loss associated with cisplatin...
Decibel Therapeutics to Present DB-020 Phase 1b Clinical Trial Data at the American Society of Clinical Oncology (ASCO) 2023 Annual Meeting
Data from interim analysis support DB-020 as a potential therapy to protect patients against irreversible hearing loss associated with cisplatin chemotherapy
Decibel Therapeutics to Participate in the Upcoming Barclays 2023 Gene Editing and Gene Therapy Summit
BOSTON, May 17, 2023 (GLOBE NEWSWIRE) -- Decibel Therapeutics (Nasdaq: DBTX), a clinical-stage biotechnology company dedicated to discovering and...